Liposomal Formulation of Retinoids Designed for Enzyme Triggered Release
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Liposomal Formulation of Retinoids Designed for Enzyme Triggered Release. / Pedersen, Palle J.; Adolph, Sidsel K.; Subramanian, Arun K.; Arouri, Ahmad; Andresen, Thomas L.; Mouritsen, Ole G.; Madsen, Robert; Madsen, Mogens W.; Peters, Günther H.; Clausen, Mads H.
In: Journal of Medicinal Chemistry, Vol. 53, No. 9, 2010, p. 3782-3792.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Liposomal Formulation of Retinoids Designed for Enzyme Triggered Release
AU - Pedersen, Palle J.
AU - Adolph, Sidsel K.
AU - Subramanian, Arun K.
AU - Arouri, Ahmad
AU - Andresen, Thomas L.
AU - Mouritsen, Ole G.
AU - Madsen, Robert
AU - Madsen, Mogens W.
AU - Peters, Günther H.
AU - Clausen, Mads H.
PY - 2010
Y1 - 2010
N2 - The design of retinoid phospholipid prodrugs is described based on molecular dynamics simulations and cytotoxicity studies of synthetic retinoid esters. The prodrugs are degradable by secretory phospholipase A2 IIA and have potential in liposomal drug delivery targeting tumors. We have synthesized four different retinoid phospholipid prodrugs and shown that they form particles in the liposome size region with average diameters of 94-118 nm. Upon subjection to phospholipase A2, the lipid prodrugs were hydrolyzed, releasing cytotoxic retinoids and lysolipids. The formulated lipid prodrugs displayed IC50 values in the range of 3-19 μM toward HT-29 and Colo205 colon cancer cells in the presence of phospholipase A 2, while no significant cell death was observed in the absence of the enzyme.
AB - The design of retinoid phospholipid prodrugs is described based on molecular dynamics simulations and cytotoxicity studies of synthetic retinoid esters. The prodrugs are degradable by secretory phospholipase A2 IIA and have potential in liposomal drug delivery targeting tumors. We have synthesized four different retinoid phospholipid prodrugs and shown that they form particles in the liposome size region with average diameters of 94-118 nm. Upon subjection to phospholipase A2, the lipid prodrugs were hydrolyzed, releasing cytotoxic retinoids and lysolipids. The formulated lipid prodrugs displayed IC50 values in the range of 3-19 μM toward HT-29 and Colo205 colon cancer cells in the presence of phospholipase A 2, while no significant cell death was observed in the absence of the enzyme.
U2 - 10.1021/jm100190c
DO - 10.1021/jm100190c
M3 - Journal article
C2 - 20405849
AN - SCOPUS:77952020524
VL - 53
SP - 3782
EP - 3792
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
SN - 0022-2623
IS - 9
ER -
ID: 230976626